Published in Proc Natl Acad Sci U S A on July 01, 2002
Structure of the cross-beta spine of amyloid-like fibrils. Nature (2005) 11.56
A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A (2002) 9.55
Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry (2006) 6.54
Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A (2008) 4.84
Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A (2004) 3.64
High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci U S A (2004) 3.58
Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry (2007) 3.57
AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. BMC Bioinformatics (2007) 3.02
The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol (2014) 2.99
De novo designed peptide-based amyloid fibrils. Proc Natl Acad Sci U S A (2002) 2.59
Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci U S A (2006) 2.46
FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils. Protein Sci (2004) 2.31
Folding versus aggregation: polypeptide conformations on competing pathways. Arch Biochem Biophys (2007) 1.97
Paired beta-sheet structure of an Abeta(1-40) amyloid fibril revealed by electron microscopy. Proc Natl Acad Sci U S A (2008) 1.89
An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci U S A (2004) 1.85
Polymorphic fibril formation by residues 10-40 of the Alzheimer's beta-amyloid peptide. Biophys J (2006) 1.84
Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences. Protein Sci (2005) 1.80
Parallel beta-sheets and polar zippers in amyloid fibrils formed by residues 10-39 of the yeast prion protein Ure2p. Biochemistry (2005) 1.79
Atomic structure and hierarchical assembly of a cross-β amyloid fibril. Proc Natl Acad Sci U S A (2013) 1.75
3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR. Proc Natl Acad Sci U S A (2006) 1.70
Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy. Biophys J (2004) 1.65
Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape. Chem Rev (2010) 1.62
Amyloid structure: conformational diversity and consequences. Annu Rev Biochem (2011) 1.57
A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biol (2007) 1.56
Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J Chem Biol (2009) 1.55
Toxic fibrillar oligomers of amyloid-β have cross-β structure. Proc Natl Acad Sci U S A (2012) 1.53
The structural biology of protein aggregation diseases: Fundamental questions and some answers. Acc Chem Res (2006) 1.47
Molecular basis for insulin fibril assembly. Proc Natl Acad Sci U S A (2009) 1.47
Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM. Proc Natl Acad Sci U S A (2009) 1.45
A three-stage kinetic model of amyloid fibrillation. Biophys J (2007) 1.44
Beta arcades: recurring motifs in naturally occurring and disease-related amyloid fibrils. FASEB J (2009) 1.37
Structural polymorphism of Alzheimer Abeta and other amyloid fibrils. Prion (2009) 1.35
Mimicking phosphorylation of alphaB-crystallin affects its chaperone activity. Biochem J (2007) 1.34
A Structural-informatics approach for tracing beta-sheets: building pseudo-C(alpha) traces for beta-strands in intermediate-resolution density maps. J Mol Biol (2004) 1.34
Rapid amyloid fiber formation from the fast-folding WW domain FBP28. Proc Natl Acad Sci U S A (2003) 1.33
Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass. Proc Natl Acad Sci U S A (2007) 1.29
Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc Natl Acad Sci U S A (2004) 1.23
Globular tetramers of beta(2)-microglobulin assemble into elaborate amyloid fibrils. J Mol Biol (2009) 1.21
Two amyloid States of the prion protein display significantly different folding patterns. J Mol Biol (2010) 1.16
Sulfates dramatically stabilize a salt-dependent type of glucagon fibrils. Biophys J (2006) 1.15
Amyloid fibrils: abnormal protein assembly. Prion (2008) 1.15
Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformation. Biophys J (2009) 1.13
Amyloid fibrils of glucagon characterized by high-resolution atomic force microscopy. Biophys J (2006) 1.12
Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophys J (2004) 1.12
Structural analysis and mapping of individual protein complexes by infrared nanospectroscopy. Nat Commun (2013) 1.10
Molecular alignment within beta-sheets in Abeta(14-23) fibrils: solid-state NMR experiments and theoretical predictions. Biophys J (2006) 1.09
Protective hinge in insulin opens to enable its receptor engagement. Proc Natl Acad Sci U S A (2014) 1.08
Insulin fibrillation and protein design: topological resistance of single-chain analogs to thermal degradation with application to a pump reservoir. J Diabetes Sci Technol (2012) 1.07
Stability and structure of oligomers of the Alzheimer peptide Abeta16-22: from the dimer to the 32-mer. Biophys J (2006) 1.07
The non-core regions of human lysozyme amyloid fibrils influence cytotoxicity. J Mol Biol (2010) 1.07
Amyloid-a state in many guises: survival of the fittest fibril fold. Protein Sci (2007) 1.06
Dichotomous versus palm-type mechanisms of lateral assembly of amyloid fibrils. Protein Sci (2006) 1.04
Site-specific identification of non-beta-strand conformations in Alzheimer's beta-amyloid fibrils by solid-state NMR. Biophys J (2003) 1.04
Observation of spatial propagation of amyloid assembly from single nuclei. Proc Natl Acad Sci U S A (2011) 1.04
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials. Chem Rev (2015) 1.03
Intrinsic fibrillation of fast-acting insulin analogs. J Diabetes Sci Technol (2012) 1.03
Amyloid protofibrils of lysozyme nucleate and grow via oligomer fusion. Biophys J (2009) 1.00
Physical and structural basis for polymorphism in amyloid fibrils. Protein Sci (2014) 0.99
Structure and composition of insulin fibril surfaces probed by TERS. J Am Chem Soc (2012) 0.99
Formation and growth of oligomers: a Monte Carlo study of an amyloid tau fragment. PLoS Comput Biol (2008) 0.99
Deciphering the structure, growth and assembly of amyloid-like fibrils using high-speed atomic force microscopy. PLoS One (2010) 0.97
Structural characterization of GNNQQNY amyloid fibrils by magic angle spinning NMR. Biochemistry (2010) 0.96
Intrinsic linear heterogeneity of amyloid β protein fibrils revealed by higher resolution mass-per-length determinations. J Biol Chem (2010) 0.96
Nucleation and growth of insulin fibrils in bulk solution and at hydrophobic polystyrene surfaces. Biophys J (2007) 0.96
Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration. Front Neurol (2013) 0.96
Simulations of nucleation and elongation of amyloid fibrils. J Chem Phys (2009) 0.95
Thermodynamic description of polymorphism in Q- and N-rich peptide aggregates revealed by atomistic simulation. Biophys J (2009) 0.95
Existence of different structural intermediates on the fibrillation pathway of human serum albumin. Biophys J (2009) 0.95
Perturbation of the stability of amyloid fibrils through alteration of electrostatic interactions. Biophys J (2011) 0.94
Disulfide bridges remain intact while native insulin converts into amyloid fibrils. PLoS One (2012) 0.94
Insulin amyloid fibrillation at above 100 degrees C: new insights into protein folding under extreme temperatures. Protein Sci (2004) 0.92
Supersaturation-limited amyloid fibrillation of insulin revealed by ultrasonication. J Biol Chem (2014) 0.91
Normal and reversed supramolecular chirality of insulin fibrils probed by vibrational circular dichroism at the protofilament level of fibril structure. Biophys J (2012) 0.91
An Achilles' heel in an amyloidogenic protein and its repair: insulin fibrillation and therapeutic design. J Biol Chem (2010) 0.91
Alzheimer's abeta(1-40) amyloid fibrils feature size-dependent mechanical properties. Biophys J (2010) 0.90
Time-dependent insulin oligomer reaction pathway prior to fibril formation: cooling and seeding. Proteins (2009) 0.89
Insights into the architecture of the Ure2p yeast protein assemblies from helical twisted fibrils. Protein Sci (2006) 0.89
Characterization of amyloid structures at the molecular level by solid state nuclear magnetic resonance spectroscopy. Methods Enzymol (2006) 0.89
A generic crystallization-like model that describes the kinetics of amyloid fibril formation. J Biol Chem (2012) 0.88
Molecular structures of quiescently grown and brain-derived polymorphic fibrils of the Alzheimer amyloid abeta9-40 peptide: a comparison to agitated fibrils. PLoS Comput Biol (2010) 0.88
Molecular origin of the self-assembly of lanreotide into nanotubes: a mutational approach. Biophys J (2007) 0.88
Disulfide bonds reduce the toxicity of the amyloid fibrils formed by an extracellular protein. Angew Chem Int Ed Engl (2011) 0.88
Chemical modification of insulin in amyloid fibrils. Protein Sci (2003) 0.87
MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. PLoS One (2012) 0.87
Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation. BMC Biochem (2011) 0.86
The mechanism of enhanced insulin amyloid fibril formation by NaCl is better explained by a conformational change model. PLoS One (2011) 0.86
Formation kinetics of insulin-based amyloid gels and the effect of added metalloporphyrins. Biophys J (2005) 0.86
Structure of human insulin monomer in water/acetonitrile solution. J Biomol NMR (2007) 0.86
Structural similarity of wild-type and ALS-mutant superoxide dismutase-1 fibrils using limited proteolysis and atomic force microscopy. Proc Natl Acad Sci U S A (2013) 0.85
Early stages of amyloid fibril formation studied by liquid-state NMR: the peptide hormone glucagon. Biophys J (2008) 0.85
Systematic examination of polymorphism in amyloid fibrils by molecular-dynamics simulation. Biophys J (2011) 0.85
Surface characterization of insulin protofilaments and fibril polymorphs using tip-enhanced Raman spectroscopy (TERS). Biophys J (2014) 0.85
Formation of dynamic soluble surfactant-induced amyloid β peptide aggregation intermediates. J Biol Chem (2013) 0.85
Amyloid features and neuronal toxicity of mature prion fibrils are highly sensitive to high pressure. J Biol Chem (2011) 0.85
Computational assembly of polymorphic amyloid fibrils reveals stable aggregates. Biophys J (2013) 0.85
The Structural Architecture of an Infectious Mammalian Prion Using Electron Cryomicroscopy. PLoS Pathog (2016) 0.85
Optical microscopy of growing insulin amyloid spherulites on surfaces in vitro. Biophys J (2005) 0.84
Morphology and mechanical stability of amyloid-like peptide fibrils. J Mater Sci Mater Med (2007) 0.84
Revealing different aggregation pathways of amyloidogenic proteins by ultrasound velocimetry. Biophys J (2008) 0.84
Controlling the aggregation and rate of release in order to improve insulin formulation: molecular dynamics study of full-length insulin amyloid oligomer models. J Mol Model (2011) 0.84
Prions. Proc Natl Acad Sci U S A (1998) 27.80
SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields. J Struct Biol (1996) 22.89
A new generation of the IMAGIC image processing system. J Struct Biol (1996) 12.57
Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell (1993) 10.15
Protein misfolding, evolution and disease. Trends Biochem Sci (1999) 7.73
Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol (1997) 7.27
Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell (1997) 5.24
Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A (1999) 4.71
X-ray diffraction studies on amyloid filaments. J Histochem Cytochem (1968) 4.54
Amyloid fibrils from muscle myoglobin. Nature (2001) 3.93
Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A (2000) 3.86
Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J (1999) 3.72
The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci (2001) 3.65
Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure (1996) 3.58
Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry (1992) 3.19
Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem Biol (1997) 3.05
Conformational diversity in a yeast prion dictates its seeding specificity. Nature (2001) 2.44
pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J (1991) 2.33
Atomic positions in rhombohedral 2-zinc insulin crystals. Nature (1971) 2.31
Polymorphic fibrillar assembly of human amylin. J Struct Biol (1997) 2.26
Image reconstruction of the Alzheimer paired helical filament. EMBO J (1985) 1.82
Direct visualisation of the beta-sheet structure of synthetic Alzheimer's amyloid. J Mol Biol (2000) 1.77
Cross- protein structures. I. Insulin fibrils. Biochemistry (1972) 1.72
The protofilament substructure of amyloid fibrils. J Mol Biol (2000) 1.69
Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy. Proc Natl Acad Sci U S A (1999) 1.63
Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry (2001) 1.61
Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia (1988) 1.60
Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys J (2000) 1.58
PHOELIX: a package for semi-automated helical reconstruction. Ultramicroscopy (1995) 1.51
Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J Struct Biol (1995) 1.47
Ultrastructural organization of amyloid fibrils by atomic force microscopy. Biophys J (2000) 1.46
SUPRIM: easily modified image processing software. J Struct Biol (1996) 1.41
Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy. J Pharm Sci (2001) 1.38
Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain. Neurosci Lett (2000) 1.27
Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy. J Mol Biol (2001) 1.11
Dissecting the hydrogen exchange properties of insulin under amyloid fibril forming conditions: a site-specific investigation by mass spectrometry. J Mol Biol (2000) 0.99
Refined fibril structures: the hydrophobic core in Alzheimer's amyloid beta-protein and prion as revealed by X-ray diffraction. Ciba Found Symp (1996) 0.94
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature (2002) 10.81
Mechanism of auxin perception by the TIR1 ubiquitin ligase. Nature (2007) 8.21
Simultaneous determination of protein structure and dynamics. Nature (2005) 5.28
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med (Berl) (2003) 5.15
Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature (2003) 4.98
Targeting C-reactive protein for the treatment of cardiovascular disease. Nature (2006) 4.07
Long-range interactions within a nonnative protein. Science (2002) 4.06
Protein structure determination from NMR chemical shifts. Proc Natl Acad Sci U S A (2007) 3.96
An analytical solution to the kinetics of breakable filament assembly. Science (2009) 3.87
A tandem mass spectrometer for improved transmission and analysis of large macromolecular assemblies. Anal Chem (2002) 3.83
Amyloid formation by globular proteins under native conditions. Nat Chem Biol (2009) 3.72
Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem (2009) 3.66
Determining the stoichiometry and interactions of macromolecular assemblies from mass spectrometry. Nat Protoc (2007) 3.64
High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci U S A (2004) 3.58
Ion mobility-mass spectrometry analysis of large protein complexes. Nat Protoc (2008) 3.51
In vitro reconstitution of the human RISC-loading complex. Proc Natl Acad Sci U S A (2008) 3.43
Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell (2012) 3.39
Evidence for macromolecular protein rings in the absence of bulk water. Science (2005) 3.26
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J Mol Biol (2005) 3.18
Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J Am Chem Soc (2005) 3.13
Role of intermolecular forces in defining material properties of protein nanofibrils. Science (2007) 2.94
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A (2013) 2.89
Structural basis of pore formation by the bacterial toxin pneumolysin. Cell (2005) 2.87
Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR. Nature (2004) 2.84
The importance of sequence diversity in the aggregation and evolution of proteins. Nature (2005) 2.70
Structures of SAS-6 suggest its organization in centrioles. Science (2011) 2.67
Structure of an Hsp90-Cdc37-Cdk4 complex. Mol Cell (2006) 2.62
Collision cross sections of proteins and their complexes: a calibration framework and database for gas-phase structural biology. Anal Chem (2010) 2.62
De novo designed peptide-based amyloid fibrils. Proc Natl Acad Sci U S A (2002) 2.59
The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J (2002) 2.59
Protein complexes in the gas phase: technology for structural genomics and proteomics. Chem Rev (2007) 2.57
Structural basis for the regulated protease and chaperone function of DegP. Nature (2008) 2.56
Structural organization of the 19S proteasome lid: insights from MS of intact complexes. PLoS Biol (2006) 2.56
Prediction of aggregation-prone regions in structured proteins. J Mol Biol (2008) 2.56
Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3. Proc Natl Acad Sci U S A (2008) 2.50
A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol (2010) 2.48
Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci U S A (2006) 2.46
Micelles protect membrane complexes from solution to vacuum. Science (2008) 2.40
Molecular recycling within amyloid fibrils. Nature (2005) 2.39
The role of mass spectrometry in structure elucidation of dynamic protein complexes. Annu Rev Biochem (2007) 2.39
Kinetic partitioning of protein folding and aggregation. Nat Struct Biol (2002) 2.37
Structure of a type IV secretion system core complex. Science (2009) 2.36
Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. PLoS Biol (2007) 2.35
Mass measurements of increased accuracy resolve heterogeneous populations of intact ribosomes. J Am Chem Soc (2006) 2.31
Symmetrical modularity of the COP9 signalosome complex suggests its multifunctionality. Structure (2009) 2.30
Assembly reflects evolution of protein complexes. Nature (2008) 2.27
The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature (2010) 2.23
Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril. Proc Natl Acad Sci U S A (2002) 2.18
Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. J Mol Biol (2009) 2.14
Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol (2004) 2.14
The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat Struct Mol Biol (2010) 2.08
Structural insights into the activity of enhancer-binding proteins. Science (2005) 2.04
The TatA component of the twin-arginine protein transport system forms channel complexes of variable diameter. Proc Natl Acad Sci U S A (2005) 2.02
Friend or foe: the same fold for attack and defense. Trends Immunol (2008) 1.99
Tandem mass spectrometry reveals the quaternary organization of macromolecular assemblies. Chem Biol (2006) 1.96
Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat Commun (2011) 1.96
Crystal structures of truncated alphaA and alphaB crystallins reveal structural mechanisms of polydispersity important for eye lens function. Protein Sci (2010) 1.95
Structural basis for protein-protein interactions in the 14-3-3 protein family. Proc Natl Acad Sci U S A (2006) 1.95
Allosteric signaling of ATP hydrolysis in GroEL-GroES complexes. Nat Struct Mol Biol (2006) 1.94
Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc Natl Acad Sci U S A (2003) 1.93
Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci (2006) 1.89
Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci (2007) 1.88
An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem (2009) 1.85
Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A (2004) 1.83
Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci U S A (2002) 1.80
Structural basis for the subunit assembly of the anaphase-promoting complex. Nature (2011) 1.80
The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J (2007) 1.79
Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem (2004) 1.79
Recognition of a signal peptide by the signal recognition particle. Nature (2010) 1.77
Polydispersity of a mammalian chaperone: mass spectrometry reveals the population of oligomers in alphaB-crystallin. Proc Natl Acad Sci U S A (2003) 1.76
Atomic structure and hierarchical assembly of a cross-β amyloid fibril. Proc Natl Acad Sci U S A (2013) 1.75
Subunit architecture of multimeric complexes isolated directly from cells. EMBO Rep (2006) 1.75
The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J Mol Biol (2005) 1.74
Structure of the CRISPR interference complex CSM reveals key similarities with cascade. Mol Cell (2013) 1.74
Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Proc Natl Acad Sci U S A (2010) 1.72
From macroscopic measurements to microscopic mechanisms of protein aggregation. J Mol Biol (2012) 1.71
Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Mol Cell Proteomics (2007) 1.71
Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput Biol (2007) 1.71
Protein complexes of the Escherichia coli cell envelope. J Biol Chem (2005) 1.69
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature (2003) 1.66
Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat Struct Biol (2002) 1.64
Quaternary dynamics and plasticity underlie small heat shock protein chaperone function. Proc Natl Acad Sci U S A (2010) 1.63
Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation. Structure (2005) 1.63
The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide. Nat Struct Mol Biol (2011) 1.62
Mass spectrometry of macromolecular assemblies: preservation and dissociation. Curr Opin Struct Biol (2006) 1.62
The mechanism of pore formation by bacterial toxins. Curr Opin Struct Biol (2006) 1.61
Aspects of native proteins are retained in vacuum. Curr Opin Chem Biol (2006) 1.61
Studies of the RNA degradosome-organizing domain of the Escherichia coli ribonuclease RNase E. J Mol Biol (2004) 1.60
Direct characterization of amyloidogenic oligomers by single-molecule fluorescence. Proc Natl Acad Sci U S A (2008) 1.56
Nanobodies raised against monomeric α-synuclein distinguish between fibrils at different maturation stages. J Mol Biol (2013) 1.56
Atypical AAA+ subunit packing creates an expanded cavity for disaggregation by the protein-remodeling factor Hsp104. Cell (2007) 1.56
Exploring amyloid formation by a de novo design. Proc Natl Acad Sci U S A (2004) 1.55
Intermolecular structure determination of amyloid fibrils with magic-angle spinning and dynamic nuclear polarization NMR. J Am Chem Soc (2011) 1.54
Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology (2005) 1.54